Listen Live
Donate
 on air
    Schedule

    KCRW

    Read & Explore

    • News
    • Entertainment
    • Food
    • Culture
    • Events

    Listen

    • Live Radio
    • Music
    • Podcasts
    • Full Schedule

    Information

    • About
    • Careers
    • Help / FAQ
    • Newsletters
    • Contact

    Support

    • Become a Member
    • Become a VIP
    • Ways to Give
    • Shop
    • Member Perks

    Become a Member

    Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

    DonateGive Monthly

    Copyright 2026 KCRW. All rights reserved.

    Report a Bug|Privacy Policy|Terms of Service|
    Cookie Policy
    |FCC Public Files|

    Back to Press Play with Madeleine Brand

    Press Play with Madeleine Brand

    Can enough Americans get vaccinated before COVID mutations demand different inoculations?

    Dr. Anthony Fauci says the U.K. coronavirus variant could become the dominant strain in the U.S. by the end of March.

    • rss
    • Share
    By Madeleine Brand • Feb 8, 2021 • 11m Listen

    Dr. Anthony Fauci says the U.K. coronavirus variant could become the dominant strain in the U.S. by the end of March.

    He spoke to the Biden administration’s senior COVID advisor Andy Slavitt today: “Modeling would tell us … that it could become dominant by the end of March. That’s the sobering news. The encouraging news is that the vaccines that we’re currently distributing right now are quite effective against that particular variant. Less so against the South African … but hopefully we will get the virus under much better control by the time there’s any indication that that might become dominant.”

    The U.K. variant is doubling every 10 days in the U.S., according to a report out Sunday.

    Other worrisome variants of the virus have also been discovered here in the U.S. — one from South Africa and another from Brazil.

    Over the weekend, officials in South Africa put the rollout of the Oxford-AstraZeneca vaccine on hold. That was after a small study found that the vaccine wasn’t effective at preventing mild or moderate COVID symptoms.

    • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

      Madeleine Brand

      Host, 'Press Play'

    • KCRW placeholder

      Sarah Sweeney

      Vice President of Talk Programming, KCRW

    • KCRW placeholder

      Angie Perrin

      Producer, Press Play

    • KCRW placeholder

      Michell Eloy

      Line Editor, Press Play

    • KCRW placeholder

      Zeynep Tufecki

      Professor at University of North Carolina’s School of Information and Library Science

      NewsCoronavirusHealth & WellnessNationalInternational
    Back to Press Play with Madeleine Brand